Bigskytraveller
Newbie
- Joined
- May 6, 2021
- Posts
- 9
With regards to Seychelles, Chile have found the first dose of Sinovac is very specific in its lower efficacy than any other vaccine… sadly Chile are paying the price with that.
AZ is sold at cost and all manufacturing locations must agree to that, it was a condition of the UK govt and Oxford that during the pandemic the vaccine was provided at cost, hence it being much cheaper than many others. Also the idea it would be licensed for manufacturing in third party locations rather than only company controlled factories. I have no AZ affiliation but I’d also look closely at the efficacy data, AZ in at scale use compares well with Pfizer etc.
There’s no question the rollout in Australia is too slow, the message about what the vaccine does for the individual, their family and the country is also lacking. When I hear Australian politicians talking *still* about how we don’t know whether the vaccines lower transmission I’m stunned. Lots of data now shows transmission in vaccinated groups is reduced by at least two thirds.
The govt needs to get its act together and say to the Australian public - here’s the deal. You’ll be offered 2 doses and a variant tweaked booster by this date - realistically Q1 2022, if you’re 12 or older (maybe 6 by early 2022 but 12 is the new youngest age cohort vaccines are approved for). In Q2 2022 we are going to allow vaccine passport quarantine free travel for Australians and visitors with certified vaccines from moderate risk locations, vaccinated travellers from high risk locations can do a 3 day home quarantine with test to release. If you haven’t had your vaccine you will be at greater risk. At least that’s then a plan at present we have no plan, no statement of benefit, no timeline…
Chile Covid-19 vaccination drive adds to Sinovac efficacy data
As the country grapples with rising infections, results from its vaccinated population echo Brazil’s trial of the Chinese jab.
www.scmp.com
AZ is sold at cost and all manufacturing locations must agree to that, it was a condition of the UK govt and Oxford that during the pandemic the vaccine was provided at cost, hence it being much cheaper than many others. Also the idea it would be licensed for manufacturing in third party locations rather than only company controlled factories. I have no AZ affiliation but I’d also look closely at the efficacy data, AZ in at scale use compares well with Pfizer etc.
There’s no question the rollout in Australia is too slow, the message about what the vaccine does for the individual, their family and the country is also lacking. When I hear Australian politicians talking *still* about how we don’t know whether the vaccines lower transmission I’m stunned. Lots of data now shows transmission in vaccinated groups is reduced by at least two thirds.
The govt needs to get its act together and say to the Australian public - here’s the deal. You’ll be offered 2 doses and a variant tweaked booster by this date - realistically Q1 2022, if you’re 12 or older (maybe 6 by early 2022 but 12 is the new youngest age cohort vaccines are approved for). In Q2 2022 we are going to allow vaccine passport quarantine free travel for Australians and visitors with certified vaccines from moderate risk locations, vaccinated travellers from high risk locations can do a 3 day home quarantine with test to release. If you haven’t had your vaccine you will be at greater risk. At least that’s then a plan at present we have no plan, no statement of benefit, no timeline…